Get In Touch
  • According to Transparency Market Research’s latest report on the global chemiluminescence immunoassay (CLIA) analyzers market for the historical period 2017 - 2018 and forecast period 2019-2027, high incidence & prevalence of chronic diseases to escalate the growth of global chemiluminescence immunoassay (CLIA) analyzers market. Moreover, increase in demand for laboratory automation is boost the growth of market
  • According to the report, the global chemiluminescence immunoassay (CLIA) analyzers market was valued at US$ 5.04 Bn in 2018 and is anticipated to expand at a CAGR of 6.3% from 2019 to 2027

Request a sample to get extensive insights into the Chemiluminescence Immunoassay (CLIA) Analyzers Market

Growing Demand for International Accreditations and Result Comparability Using High Throughput Automated Immunoassays and Increase in Prevalence of Chronic Diseases : Key Drivers of Global Chemiluminescence Immunoassay (CLIA) Analyzers Market

  • Sedentary lifestyle and unhealthy diet is leading to surge in prevalence & incidence of chronic diseases. For instance, according to World Health Organization (WHO), in 2018 cancer burden is estimated to have risen to 18.1 million new cases and 9.6 million deaths globally.  
  • Chronic disease prevalence has increased over time due to an aging population. Moreover, smoking, and body mass index, which are widely known risk factors for chronic diseases such as cancer, cardiovascular disease, etc. thus rise in prevalence of various chronic diseases propel the growth of market
  • Moreover, major focus of physicians and pathologists operating in in-patient or out-patient settings of the chemiluminescence immunoassay (CLIA) analyzers market is to improve the rate of standardization of the assays. The main objective behind calibration of the assays is to compare the results of the test to the well-established standards while handing out the test results to patients.
  • The CLIA instruments are closed system multiplexed automated analyzers along with high throughput. These systems are relatively easy to calibrate. The CLIA analyzers are manufactured as per guidelines set by regulatory authorities. The CLIA test manufacturers also offer internal reference standard material to make their results more comparable when compared with other manual assay systems.
  • Thus, growing demand for international accreditations and result comparability using high throughput automated immunoassays is likely to drive the global chemiluminescence immunoassay (CLIA) analyzers market
  • To address these demands, the industry players are investing in the research and development activities to develop and introduce new products thereby boosting the global chemiluminescence immunoassay (CLIA) analyzers market

To understand how our report can bring difference to your business strategy, Ask for a brochure

Technological Advancements Propel Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Growth

  • A major technological trend observed in the global chemiluminescence immunoassay analyzers market is the introduction of next-generation integrated immunoassays. For instance, in October 31, 2017, Abbott announced the FDA 510(k) clearance for Alinity ci-series, instruments for clinical chemistry and immunoassay diagnostics. This innovation in multiplexed assays is likely to drive the global CLIA analyzers market during the forecast period
  • Moreover, major manufacturers operating in the global CLIA analyzers market are involved in the expansion of their test portfolio through continuous research and development activities. For instance, in December 26, 2017, Danaher (Beckman Coulter, Inc.) received FDA clearance for its Access AMH immunoassay, the first immunoassay that uses recombinant human antigens for determination of anti-Müllerian hormone (AMH) levels. The increasing preference for continuous research with an objective of expansion of test portfolio by major as well as emerging players is likely to result in growth of the global CLIA analyzers market during the forecast period

Stuck in a neck-to-neck competition with other brands? Request a custom report on Chemiluminescence Immunoassay (CLIA) Analyzers Market

Fragmented Consumables Market Affecting Profit Margin to Hamper Global Chemiluminescence Immunoassay (CLIA) Analyzers Market

  • Continuous expansion of test offering portfolio has resulted in increasing number of emerging market players offering test kits for specific test application at affordable prices
  • Product offering at relatively lower average selling price has resulted in increasing market penetration of local players having wide distribution network in certain geographies
  • This is imposing pricing pressure on major manufacturers, thereby intensifying competition. Additionally, there are other technology alternatives that are available in the market at relatively lower cost per procedure, which is also affecting the geographic expansion of major players.

Global Chemiluminescence Immunoassay (CLIA) Analyzers Market: Competitive Landscape

  • This report profiles major players in the global chemiluminescence immunoassay (CLIA) analyzers market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global chemiluminescence immunoassay (CLIA) analyzers market is highly fragmented, with the presence of a number of international as well as regional players
  • Leading players operating in the global chemiluminescence immunoassay (CLIA) analyzers market are -
    • Abbott
    • F. Hoffmann-La Roche Ltd
    • Siemens Healthineers (Siemens AG)
    • Danaher (Beckman Coulter, Inc.)
    • DiaSorin S.p.A
    • Ortho Clinical Diagnostics (Part of Carlyle Group)
    • Shenzhen New Industries Biomedical Engineering Co., Ltd.
    • Sysmex Corporation
    • Randox Laboratories Ltd.
    • Tosoh Corporation

Global Chemiluminescence Immunoassay (CLIA) Analyzers Market: Key Developments

Key players in the global chemiluminescence immunoassay (CLIA) analyzers market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global chemiluminescence immunoassay (CLIA) analyzers market. A few expansion strategies adopted by players operating in the global chemiluminescence immunoassay (CLIA) analyzers market are:

  • In June 2020, Abbott announced that it has begun supply of its laboratory-based serology blood test for the detection of the antibody, IgG for identification if COVID-19. This is enabled to contribute to ICMR’s COVID-19 antibody testing strategy to use IgG CLIA antibody tests
  • In January 2018, DiaSorin S.p.A. partnered with QIAGEN N.V. to add the latter’s QuantiFERON-TB diagnostic test to the former’s LIAISON family of fully automated analyzers.
  • In October, 2017, Abbott announced the acquisition of Alere Inc., a provider of diagnostic devices and services

The report on the global chemiluminescence immunoassay (CLIA) analyzers market discussed individual strategies, followed by company profiles of manufacturers of chemiluminescence immunoassay (CLIA) analyzers. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global chemiluminescence immunoassay (CLIA) analyzers market.

TMR’s report on the global chemiluminescence immunoassay (CLIA) analyzers market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators of the market during the forecast period from 2019 to 2027. The report provides revenue of the global chemiluminescence immunoassay (CLIA) analyzers market for the period 2017–2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global chemiluminescence immunoassay (CLIA) analyzers market during the forecast period.

The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global chemiluminescence immunoassay (CLIA) analyzers market.

Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global chemiluminescence immunoassay (CLIA) analyzers market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global chemiluminescence immunoassay (CLIA) analyzers market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global chemiluminescence immunoassay (CLIA) analyzers market.

The report delves into the competitive landscape of the global chemiluminescence immunoassay (CLIA) analyzers market. Key players operating in the global chemiluminescence immunoassay (CLIA) analyzers market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global chemiluminescence immunoassay (CLIA) analyzers market that have been profiled in this report

Key Questions Answered in Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Report

  • What is the scope of growth for product companies in the global chemiluminescence immunoassay (CLIA) analyzers market?
  • What will be the Y-o-Y growth of the global chemiluminescence immunoassay (CLIA) analyzers market between 2019 and 2027?
  • What is the influence of changing trends in technologies on the global chemiluminescence immunoassay (CLIA) analyzers market?
  • Will North America continue to be the most profitable market for chemiluminescence immunoassay (CLIA) analyzers providers?
  • Which factors are anticipated to hamper the growth of the global chemiluminescence immunoassay (CLIA) analyzers market during the forecast period?
  • Which are the leading companies in the global chemiluminescence immunoassay (CLIA) analyzers market?

Research Methodology

A unique research methodology has been utilized by TMR to conduct comprehensive research on the growth of the global chemiluminescence immunoassay (CLIA) analyser market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary research sources referred to by analysts during the production of the global chemiluminescence immunoassay (CLIA) analyzer market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the chemiluminescence immunoassay (CLIA) analyser market as primary methods.

These primary research respondents have provided exclusive information during interviews, which serves as a validation from the chemiluminescence immunoassay (CLIA) analyzer market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global chemiluminescence immunoassay (CLIA) analyser market with accuracy. The study also uses the top-down approach to assess the revenues for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the global chemiluminescence immunoassay (CLIA) analyser more reliably and accurately.

Regional Segmentation of Chemiluminescence Immunoassay (CLIA) Analyzers Market

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa 

Global Chemiluminescence Immunoassay (CLIA) Analyzers Market - Segmentation

Product

  • Analyzers
    • Fully automated
    • Semi-automated
  • Reagents
    • Luminophore Markers
    • Enzymatic Markers
  • Consumables

Application

  • Endocrine Disorders
  • Oncology
  • Infectious Diseases
  • Hepatitis and Retrovirus
  • Cardiovascular Disorders
  • Allergy
  • Autoimmunity
  • Drug Discovery & Development
  • Others

End-user

  • Hospitals
  • Clinical Laboratories
  • Pharmaceutical & Biotechnology Industries
  • Others

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Chemiluminescence Immunoassay Analyzers Market

Buy Now